Journal List > J Bacteriol Virol > v.40(1) > 1033980

Kim, Lim, Tark, Song, and Kim: Selection of a Less Pathogenic BVDV Strain for the Construction of Avirulent Chimeric Pestivirus

Abstract

To select a less pathogenic bovine viral diarrhea virus (BVDV) strain for the construction of chimeric pestivirus harboring classical swine fever virus (CSFV) E2 gene, five Korean BVDV isolates (four type 1 isolates and a type 2 isolate) were evaluated for their pathological and biological properties with respect to porcine infection. Each of five groups of 100-day-old pigs was inoculated intranasally with one of the five BVDV isolates. No clinical sign or leukopenia was observed in any pig throughout the duration of the experiment, but viruses were detected in blood, nasal discharges and postmortem samples using RT-PCR. These results indicated that although the five BVD viruses could infect pigs, they did not cause clinically apparent symptoms. Because of its proper infection dynamics shown in this preliminary animal study and its fast growth rate and quick CPE in cell culture, one isolate (KD26-1) was chosen among the five isolates to test its virulence and immunogenic properties in 40-day-old piglets. Neither clinical sign nor pathological lesion was observed in 40-day-old piglets during the course of infection of isolate KD26-1. The first neutralizing antibodies were detectable 14 days post-inoculation (PI) and increased to 1:128~1:256 28 days PI. A BVDV specific gene was detectable by RT-PCR in tonsil, spleen, inguinal lymph node and brain until 14 days PI. According to this study, it can be concluded that isolate KD26-1 has little pathological effect in pigs and is a candidate for construction of chimeric pestivirus harboring CSFV E2 gene.

REFERENCES

1). Thiel HJ., Plagemann PGW., Moenning V. Pestiviruses. Fields BN, Knipe DM, Howley PM, editors. editors.Fields Virology. 3rd ed.New York: Raven Press;1996. p. 1059–73.
2). Carbrey EA., Stewart WC., Kresse JI., Snyder ML. Natural infection of pigs with bovine viral diarrhea virus and its differential diagnosis from hog cholera. J Am Vet Med Assoc. 1976. 169:1217–9.
3). Fernelius AL., Amtower WC., Lambert G., McClurkin AW., Matthews PJ. Bovine viral diarrhea virus in swine: characteristics of virus recovered from naturally and experimentally infected swine. Can J Comp Med. 1973. 37:13–20.
4). Paton DJ., Simpson V., Done SH. Infection of pigs and cattle with bovine viral diarrhoea virus on a farm in England. Vet Rec. 1992. 131:185–8.
crossref
5). Terpstra C., Wensvoort G. Natural infections of pigs with bovine viral diarrhoea virus associated with signs resembling swine fever. Res Vet Sci. 1988. 45:137–42.
crossref
6). Ridpath JF., Bolin SR., Dubovi EJ. Segregation of bovine viral diarrhea virus into genotypes. Virology. 1994. 205:66–74.
crossref
7). Kummerer BM., Tautz N., Becher P., Thiel H., Meyers G. The genetic basis for cytopathogenicity of pestiviruses. Vet Microbiol. 2000. 77:117–28.
8). Tautz N., Meyers G., Stark R., Dubovi EJ., Thiel HJ. Cytopathogenicity of a pestivirus correlates with a 27-nucleotide insertion. J Virol. 1996. 70:7851–8.
crossref
9). Vassilev VB., Donis RO. Bovine viral diarrhea virus induced apoptosis correlates with increased intracellular viral RNA accumulation. Virus Res. 2000. 69:95–107.
crossref
10). Graham DA., Calvert V., German A., McCullough SJ. Pestiviral infections in sheep and pigs in Northern Ireland. Vet Rec. 2001. 148:69–72.
crossref
11). Fernelius AL., Amtower WC., Malmquist WA., Lambert G., Matthews PJ. Bovine viral diarrhea virus in swine: neutralizing antibody in naturally and experimentally infected swine. Can J Comp Med. 1973. 37:96–102.
12). Loeffen WL., van Beuningen A., Quak S., Elbers AR. Seroprevalence and risk factors for the presence of ruminant pestiviruses in the Dutch swine population. Vet Microbiol. 2009. 136:240–5.
crossref
13). Wieringa-Jelsma T., Quak S., Loeffen WL. Limited BVDV transmission and full protection against CSFV transmission in pigs experimentally infected with BVDV type 1b. Vet Microbiol. 2006. 118:26–36.
crossref
14). Walz PH., Baker JC., Mullaney TP., Maes RK. Experimental inoculation of pregnant swine with type 1 bovine viral diarrhoea virus. J Vet Med B Infect Dis Vet Public Health. 2004. 51:191–3.
crossref
15). Kulcsar G., Soos P., Kucsera L., Glavits R., Palfi V. Pathogenicity of a bovine viral diarrhoea virus strain in pregnant sows: short communication. Acta Vet Hung. 2001. 49:117–20.
16). Dong XN., Chen YH. Marker vaccine strategies and candidate CSFV marker vaccines. Vaccine. 2007. 25:205–30.
crossref
17). Reimann I., Depner K., Trapp S., Beer M. An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus. Virology. 2004. 322:143–57.
crossref
18). van Gennip HG., van Rijn PA., Widjojoatmodjo MN., de Smit AJ., Moormann RJ. Chimeric classical swine fever viruses containing envelope protein E(RNS) or E2 of bovine viral diarrhoea virus protect pigs against challenge with CSFV and induce a distinguishable antibody response. Vaccine. 2000. 19:447–59.
crossref
19). Gilbert SA., Burton KM., Prins SE., Deregt D. Typing of bovine viral diarrhea viruses directly from blood of persistently infected cattle by multiplex PCR. J Clin Microbiol. 1999. 37:2020–3.
crossref
20). Anonymous. Bovine Viral Diarrhoea. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (mammals, birds and bees). 6th ed.Paris: OIE;2008. p. 698–711.
21). Cho IS. Studies on serological and genetical characteristics of bovine viral diarrhea viruses isolated in Korea [PhD thesis]. Seoul: Konkuk University. 2001.
22). Paton DJ., Done SH. Congenital infection of pigs with ruminant-type pestiviruses. J Comp Pathol. 1994. 111:151–63.
crossref
23). van Oirschot JT. Diva vaccines that reduce virus transmission. J Biotechnol. 1999. 73:195–205.
crossref

Figure 1.
Leukocyte counts (103 cells/mm3) during the course of intranasal infection in the first animal study. Mean leukocyte counts in pigs inoculated with isolates KD26-1, 32669, 95589, 32527 and 95002 and those of contact pigs are given. Standard deviations are shown as error bars.
jbv-40-39f1.tif
Figure 2.
Leukocyte counts (103/mm3) of pigs after intramuscular inoculation with KD26-1 (107.5 TCID50/head). Mean leukocyte counts in pigs inoculated with isolates KD26-1 and those of contact pigs are given. Standard deviations are shown as error bars.
jbv-40-39f2.tif
Figure 3.
Virus neutralization titers of sera from pigs after intramuscular inoculation with KD26-1 (107.5 TCID50/head). Mean virus neutralization titers in pigs inoculated with isolates KD26-1 and those of contact pigs are given. Standard deviations are shown as error bars.
jbv-40-39f3.tif
Table 1.
The properties of five BVDV isolates used in animal experiments
BVD isolate Origin CPE (dpia) Genotypeb
KD26-1 Diarrhea 3~4 1
32669 Persistent infection 4~5 1
95002 Respiratory infection 6~7 2
95589 Diarrhea 4~5 1
32527 Diarrhea 4~5 1

a dpi: the number of days after which more than 80% cell death had occurred after inoculation with 0.1 MOI of each virus

b Genotype determined by RT-PCR (19)

Table 2.
RT-PCR results for detection of viral antigen from nasal swabs of five pig groups during the course of intranasal infection
Group Inoculated virus Days post inoculation
-4 0 1 2 3 4 5 7 9 11
I KD26-1 0/6a 0/6 0/6 2/6 0/6 1/6 0/6 2/6 0/4 0/2
  Contact 0/2 0/2 0/2 0/2 0/2 0/2 1/2 1/2 0/1 1/1
II 32669 0/6 0/6 1/6 1/6 0/6 0/6 0/6 0/6 0/4 0/2
  Contact 0/2 0/2 0/2 0/2 0/2 0/2 0/2 0/2 0/1 0/1
III 95002 0/6 0/6 2/6 0/6 0/6 1/6 1/6 2/6 0/4 0/2
  Contact 0/2 0/2 0/2 0/2 0/2 0/2 0/2 0/2 0/1 0/1
IV 95589 0/6 0/6 0/6 0/6 1/6 0/6 1/6 1/6 0/4 0/2
  Contact 0/2 0/2 0/2 1/2 1/2 0/2 1/2 0/2 0/1 0/1
V 32527 0/6 0/6 0/6 0/6 2/6 1/6 1/6 0/6 0/4 0/2
  Contact 0/2 0/2 0/2 0/2 0/2 0/2 1/2 1/2 1/1 0/1

a Number of positive pigs / Total number of pigs

Table 3.
RT-PCR results for detection of viral antigen from blood samples of five pig groups during the course of intranasal infection
Group Inoculated virus Days post inoculation
-4 0 1 2 3 4 5 7 9 11
I KD26-1 0/6a 0/6 0/6 0/6 1/6 1/6 1/6 0/6 0/4 0/2
  Contact 0/2 0/2 0/2 0/2 0/2 0/2 1/2 0/2 0/1 0/1
II 32669 0/6 0/6 0/6 0/6 0/6 1/6 1/6 1/6 0/4 0/2
  Contact 0/2 0/2 0/2 0/2 0/2 0/2 0/2 0/2 0/1 0/1
III 95002 0/6 0/6 0/6 0/6 0/6 0/6 1/6 0/6 0/4 0/2
  Contact 0/2 0/2 0/2 0/2 0/2 1/2 0/2 0/2 0/1 0/1
IV 95589 0/6 0/6 0/6 0/6 0/6 2/6 2/6 0/6 0/4 0/2
  Contact 0/2 0/2 0/2 0/2 0/2 0/2 0/2 0/2 0/1 0/1
V 32527 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/4 0/2
  Contact 0/2 0/2 0/2 0/2 0/2 0/2 0/2 1/2 0/1 0/1

a Number of positive pigs / Total number of pigs

Table 4.
RT-PCR detection of viral antigen from tissues samples of five pig groups at 7, 9, and 11 days PI
Group Inoculated virus 7 dpia 9 dpi 11 dpi
I KD26-1 -b Tc, Bd, Le T, B, L
  Contact NPf
II 32669 T, 2Bg, L L L
  Contact T NP
III 95002
  Contact NP
IV 95589 T
  Contact NP
V 32527 T
  Contact NP

a dpi: days post inoculation,

b –: negative in tissues

c T: positive in tonsil

d B: positive in bronchial lymph node

e L: positive in lung

f NP: not performed

g 2B: Two pigs were positive in bronchial lymph node.

Table 5.
Summary of viral antigen positive pigs (%) in thirty 100-day-old pigs inoculated intranasally with BVDV type 1 and 2
Virus type Antigen positive samples No. of pigs tested
Nasal swabs Blood Tissues
Type 1 10 (42) 9 (38) 8 (33) 24 (100)
Type 2 4 (67) 1 (17) 0 (0) 6 (100)
Table 6.
RT-PCR results for detection of viral antigen from organs of euthanized pigs after intramuscular inoculation with KD26-1 (107.5 TCID50/head)
Organ KD26-1 inoculated pigs Contact pigs
3 da 7 d 14 d 21 d 28 d 3 d 7 d 14 d 21 d 28 d
Tonsil 1/2b 1/2 1/2 0/2 0/2 0/1 0/1 0/1 0/1 0/1
Lung 0/2 0/2 0/2 0/2 0/2 0/1 0/1 0/1 0/1 0/1
Heart 0/2 0/2 0/2 0/2 0/2 0/1 0/1 0/1 0/1 0/1
Spleen 0/2 1/2 0/2 0/2 0/2 0/1 0/1 0/1 0/1 0/1
Liver 0/2 0/2 0/2 0/2 0/2 0/1 0/1 0/1 0/1 0/1
Kidney 0/2 0/2 0/2 0/2 0/2 0/1 0/1 0/1 0/1 0/1
Mesenteric LN 0/2 0/2 0/2 0/2 0/2 0/1 0/1 0/1 0/1 0/1
Ileum 0/2 0/2 0/2 0/2 0/2 0/1 0/1 0/1 0/1 0/1
Caecum 0/2 0/2 0/2 0/2 0/2 0/1 0/1 0/1 0/1 0/1
Inguinal LN 0/2 0/2 1/2 0/2 0/2 0/1 0/1 0/1 0/1 0/1
Brain 1/2 0/2 0/2 0/2 0/2 0/1 0/1 0/1 0/1 0/1

a d: days post-inoculation

b Number of pigs positive to viral antigen / Number of pigs tested

TOOLS
Similar articles